Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma.

N García-RomeroI Palacín-AlianaR MadurgaJ Carrión-NavarroS Esteban-RubioB JiménezA CollazoF Pérez-RodríguezA Ortiz de MendivilC Fernández-CarballalS García-DuqueJ Diamantopoulos-FernándezC Belda-IniestaR Prat-AcínP Sánchez-GómezE CalvoAngel Ayuso-Sacido

Published in: BMC medicine (2020)

Our data suggest that bevacizumab dose adjustment could improve clinical outcomes in Glioblastoma treatment.

Keyphrases

metastatic colorectal cancer
electronic health record